UNIGE document Scientific Article
previous document  unige:91080  next document
add to browser collection
Title

Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension

Authors
Wells, Philip S
Prins, Martin H
Levitan, Bennett
Beyer-Westendorf, Jan
Brighton, Timothy A
Cohen, Alexander T
Davidson, Bruce L
show hidden authors show all authors [1 - 14]
Published in Chest. 2016, vol. 150, no. 5, p. 1059-1068
Abstract Short-term anticoagulant treatment for acute DVT or pulmonary embolism (PE) effectively reduces the risk of recurrent disease during the first 6 to 12 months of therapy. Continued anticoagulation often is not instituted because of the perception among physicians that the risk of major bleeding will outweigh the risk of new venous thrombotic episodes.
Identifiers
PMID: 27262225
Full text
Article (Published version) (354 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group La maladie thromboembolique veineuse (808)
Citation
(ISO format)
WELLS, Philip S et al. Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension. In: Chest, 2016, vol. 150, n° 5, p. 1059-1068. https://archive-ouverte.unige.ch/unige:91080

72 hits

0 download

Update

Deposited on : 2017-01-13

Export document
Format :
Citation style :